Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Hip joint resterilization

This article was originally published in The Gray Sheet

Executive Summary

Hip joint resterilization: FDA "Dear Colleague" letter warns against steam resterilization of total hip joint prostheses with zirconia ceramic heads. Manufacturers of these devices should note that "surface roughening of zirconia ceramic femoral head components" has been associated with steam resterilization, FDA says. "As a consequence of this roughening, increased wear on the ultra-high molecular weight polyethylene acetabular component may occur, which can cause premature failure and require early revision." To avoid the phase transformation in the crystal structure of the zirconia material caused by steam and elevated temperatures, FDA recommends that manufacturers sterilize zirconia hip prostheses using ethylene oxide...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT008324

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel